ArticleBMJ open2025

Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE).

Beverley Rodger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.